卵巢癌患者肿瘤细胞减灭术异体输血危险因素分析及预测模型构建OA
Analysis of risk factors for allogeneic blood transfusion and construction of a prediction model in patients with ovar-ian cancer undergoing cytoreductive surgery
目的 探讨卵巢癌患者肿瘤细胞减灭术围手术期异体输血的独立危险因素,并构建预测模型,为临床精准评估输血风险、优化围手术期血液管理提供依据.方法 回顾性收集 2020 年 1 月至 2025 年 12 月在本院接受卵巢癌肿瘤细胞减灭术的 156 例患者临床资料,按围手术期是否接受异体输血分为输血组(n=51)与未输血组(n=105),采用 1∶1倾向性得分匹配(PSM)校正混杂因素.计量资料采用独立样本 t 检验或 Mann-Whitney U 检验,计数资料采用 χ2 检验;将单因素分析 P<0.05 的变量纳入二元 Logistic 回归进行多因素分析,确定独立危险因素.基于独立危险因素构建围手术期异体输血风险预测列线图模型,采用 Bootstrap 法(100 次抽样)开展内部校准验证,ROC曲线评估区分效能,决策曲线分析(DCA)评价模型临床净获益.结果 倾向性匹配后两组基线资料均衡可比.多因素 Logistic 回归分析显示,术前凝血酶原时间(PT)(OR=2.666,95%CI 1.249~5.693,P=0.011)、术前血红蛋白(Hb)(OR=0.953,95%CI 0.923~0.984,P=0.003)、术中出血量(OR=1.004,95%CI 1.001~1.006,P=0.004)、术前贫血分级(OR=3.052,95%CI 1.007~9.252,P=0.049)是围手术期异体输血的独立影响因素.基于上述 4 个因素构建的列线图模型整体显著(LR χ2=58.617,P<0.001),内部校准曲线显示模型预测概率与实际概率一致性良好(平均绝对误差=0.042);ROC 曲线下面积(AUC)为 0.890,提示模型具有良好的区分效能;DCA 显示 0~0.45 风险阈值区间内模型临床净收益优于统一输血/不输血策略.结论 术中出血量、术前 PT、术前 Hb、术前贫血分级是卵巢癌肿瘤细胞减灭术患者围手术期异体输血的独立危险因素.基于上述因素构建的列线图模型预测效能良好,且具备临床分层决策价值,可为临床对高危患者实施个体化血液管理、降低不必要输血率提供参考.
Objective To explore the independent risk factors of allogeneic blood transfusion during perioperative peri-od of cytoreductive surgery in patients with ovarian cancer,and to construct a predictive model to facilitate clinical risk as-sessment and optimize perioperative blood management.Methods Clinical data of 156 patients who underwent cytoreduc-tive surgery for ovarian cancer in our hospital from January 2020 to December 2025 were retrospectively collected.The pa-tients were divided into transfusion group(n=51)and non-transfusion group(n=105)according to whether they received allogeneic blood transfusion during perioperative period.The 1∶1 propensity score matching(PSM)was used to correct the confounding factors.Independent sample t test or Mann-Whitney U test was used for measurement data,and chisquare test was used for enumeration data.Variables with P<0.05 in univariate analysis were included in binary logistic regression for multivariate analysis to determine independent risk factors.A nomogram model for perioperative allogeneic blood transfusion risk prediction was constructed based on independent risk factors.Bootstrap method(100 samples)was used for internal calibration verification.ROC curve was used to evaluate the discrimination efficiency,and decision curve analysis(DCA)was used to evaluate the clinical net benefit of the model.Results After propensity matching,the baseline data of the two groups were balanced and comparable.Multivariate logistic regression analysis showed that preoperative prothrombin time(PT)(OR=2.666,95%CI 1.249~5.693,P=0.011),preoperative hemoglobin(Hb)(OR=0.953,95%CI 0.923~0.984,P=0.003),intraoperative blood loss(OR=1.004,95%CI 1.001-1.006,P=0.004),preoperative anemia grade(OR=3.052,95%CI 1.007-9.252,P=0.049)were independent influencing factors of perioperative allogeneic blood transfusion.The nomogram model based on the above four factors was significant(LR χ2=58.617,P<0.001),and the internal calibration curve showed that the predicted probability of the model was in good agreement with the actual probabili-ty(mean absolute error=0.042).The area under the ROC curve(AUC)was 0.890,indicating good discrimination effi-ciency.DCA showed that the clinical net benefit of the model was better than that of the unified transfusion/non-transfusion strategy in the 0-0.45 risk threshold range.Conclusion Intraoperative blood loss,preoperative PT,preoperative Hb and preoperative anemia grade are independent risk factors for perioperative allogeneic blood transfusion in patients undergoing cytoreductive surgery for ovarian cancer.The nomogram model based on the above factors has good predictive efficacy and clinical hierarchical decision-making value,which can provide reference for clinical implementation of individualized blood management for high-risk patients and reduction of unnecessary blood transfusion rate.
曹嘉;陈文燕;马盼盼;赵晋;唐红悦;刘建辉;耿瑞丽
河北中医药大学,河北 石家庄 050000河北省人民医院 输血科,河北 石家庄 050000河北省人民医院 输血科,河北 石家庄 050000河北省人民医院 输血科,河北 石家庄 050000河北省人民医院 输血科,河北 石家庄 050000河北省人民医院 输血科,河北 石家庄 050000河北中医药大学,河北 石家庄 050000||河北省人民医院 输血科,河北 石家庄 050000
医药卫生
卵巢癌肿瘤细胞减灭术异体输血危险因素围手术期血液管理
ovarian cancercytoreductive surgeryallogeneic blood transfusionrisk factorsperioperative blood man-agement
《中国输血杂志》 2026 (8)
1026-1032,7
河北省医学科学研究课题计划(20190353)
评论